heart failure – media

Valsartan Based Drugs Recalled by FDA

At the beginning of this month, the U.S. Food and Drug Administration (FDA) announced to withdraw drugs containing valsartan, which treat high blood pressure and heart failure. The drugs were withdrawn due to the presence of N-nitrosodimethylamine (NDMA), which might lead to cancer.
- Source: HealthLine
- 871
- July 26, 2018
blood pressure cancer FDA heart failure Policies
FDA Recalls HeartMate device Manufactured by Abbott

This will be the second recall on a heart device this month Medtronic’s Heartware device and accessories was recalled a few days ago. This comes after Abbott issued a patch to negate cybersecurity issues 350,000 remote monitoring systems and pacemakers.
- Source: Ddu
- 709
- June 7, 2018
Abbott Company Insight heart failure medical device
Mayo Clinic deal and $5m funding for health data platform Biofourmis

Singapore-based health analytics platform Biofourmis announced the close of its series A funding round, while also unveiling a partnership with US medical research institute, the Mayo Clinic.
- Source: Techinasia
- 526
- December 13, 2017
health analytics platform heart failure Series

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.